共 256 条
- [1] Khatua S(2018)Childhood medulloblastoma: Current therapies, emerging molecular landscape and newer therapeutic insights Current Neuropharmacology 16 1045-1058
- [2] Song A(2021)Current treatments of medulloblastoma Current Opinion in Oncology 33 615-620
- [3] Citla Sridhar D(2020)Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches Cancer and Metastasis Reviews 39 211-233
- [4] Mack SC(2021)Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma Cancer Letters 499 188-200
- [5] Beccaria K(2013)Gene regulation and priming by topoisomerase IIalpha in embryonic stem cells Nature Communications 4 2478-193
- [6] Padovani L(2018)DNA topoisomerase IIbeta stimulates neurite outgrowth in neural differentiated human mesenchymal stem cells through regulation of Rho-GTPases (RhoA/Rock2 pathway) and Nurr1 expression Stem Cell Research & Therapy 9 114-12
- [7] Bouchoucha Y(2014)Tetramethylpyrazine promotes SH-SY5Y cell differentiation into neurons through epigenetic regulation of Topoisomerase IIbeta Neuroscience 278 179-121
- [8] Doz F(2018)The role of E2F1-topoIIbeta signaling in regulation of cell cycle exit and neuronal differentiation of human SH-SY5Y cells Differentiation 104 1-981
- [9] Menyhart O(2021)Topoisomerase IIbeta immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: An immunohistochemical analysis of 124 medulloblastomas from the Japan Children's Cancer Group Brain Tumor Pathology 38 109-96
- [10] Gyorffy B(2017)Immunohistochemical investigation of topoIIbeta, H3K27me3 and JMJD3 expressions in medulloblastoma Pathology, Research and Practice 213 975-50